Andrés Poveda Velasco
Key information
- Latest Publication:2023 GEIS Guidelines for gastrointestinal stromal tumors.
Professional Details
Hospital Quirónsalud Valencia
SPECIALIST PHYSICIAN MEDICAL ONCOLOGY
May 2026
International Symposium on Advanced Ovarian Cancer: Optimal Therapy
October 1996
courses for postgraduate students
2023 GEIS Guidelines for gastrointestinal stromal tumors.
Journal Article, Review
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors.
Journal Article
An olaparib window-of-opportunity trial in patients with early-stage endometrial carcinoma: POLEN study.
Journal Article
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Journal Article, Review
Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression.
Journal Article
Management of advanced ovarian cancer in Spain: an expert Delphi consensus.
Journal Article
Mismatch Repair Deficiency in Ovarian Carcinoma: Frequency, Causes, and Consequences.
Journal Article
Molecular Heterogeneity of Endometrioid Ovarian Carcinoma: An Analysis of 166 Cases Using the Endometrial Cancer Subrogate Molecular Classification.
Journal Article
Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications.
Journal Article
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.
Clinical Trial, Phase III, Journal Article
Phase 2 Trial (POLA Study) of Lurbinectedin plus Olaparib in Patients with Advanced Solid Tumors: Results of Efficacy, Tolerability, and the Translational Study.
Journal Article
Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer.
Clinical Trial, Phase II, Journal Article
The Frequency and Prognostic Significance of the Histologic Type in Early-stage Ovarian Carcinoma: A Reclassification Study by the Spanish Group for Ovarian Cancer Research (GEICO).
Journal Article
The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO).
Journal Article
Italian
German
Spanish
English
Make an appointment with this professional
Articles on
View the latest articles in Tu canal de salud.
Últimas colaboraciones en tucanaldesalud.com Andrés Poveda Velasco
Artículos, entrevistas o vídeos en los que ha colaborado
- Tu salud al día
Cáncer de ovario y los síntomas que parecen una indigestión
Así se manifiesta el tumor de ovario: signos y síntomas que es importante identificar al comienzo 
Canal vídeosResolviendo dudas sobre el cáncer de mama
Andrés Poveda, especialista en Oncología Médica de Hospital Quirónsalud Valencia, nos habla de los factores de riesgo de este tipo de cáncer, los síntomas que suelen presentarse y los tratamientos disponibles en la actualidad
Vídeos de
Consulta el contenido multimedia de este profesional.
Personal health area: My Quirónsalud
Access any time of the day to take care of your health and that of your family.
My Quirónsalud is your private and secure personal space where you can request and manage your appointments or check your clinical reports without waiting, wherever you are.
Check it out!